Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centogene N.V. (NQ: CNTG )

0.4415 +0.0215 (+5.12%)
Streaming Delayed Price Updated: 10:21 AM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 973
Open 0.4303
Bid (Size) 0.4300 (5)
Ask (Size) 0.4530 (6)
Prev. Close 0.4200
Today's Range 0.4303 - 0.4415
52wk Range 0.4080 - 1.980
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Friday is here and we're breaking down the biggest pre-market stock movers that traders need to know about this morning! 
Via InvestorPlace
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Performance

YTD
-62.26%
-62.26%
1 Month
-37.82%
-37.82%
3 Month
-61.94%
-61.94%
6 Month
-69.97%
-69.97%
1 Year
-43.40%
-43.40%

More News

Read More
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via GlobeNewswire
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
From Centogene NV
Via GlobeNewswire
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
From Centogene NV
Via GlobeNewswire
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
From Centogene NV
Via GlobeNewswire
CENTOGENE Explores Strategic Alternatives
From Centogene NV
Via GlobeNewswire
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
From Centogene NV
Via GlobeNewswire
CENTOGENE Receives French Research Tax Credit Accreditation
From Centogene NV
Via GlobeNewswire
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
From Centogene NV
Via GlobeNewswire
CENTOGENE Announces Preliminary Full Year 2023 Revenue
From Centogene NV
Via GlobeNewswire
CENTOGENE Announces Voting Results of Extraordinary General Meeting
From Centogene NV
Via GlobeNewswire
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
From Centogene NV
Via GlobeNewswire
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
From Centogene NV
Via GlobeNewswire
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
From Centogene NV
Via GlobeNewswire
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
From Centogene NV
Via GlobeNewswire
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
From Centogene NV
Via GlobeNewswire
CENTOGENE Reports First Half 2023 Financial Results
From Centogene NV
Via GlobeNewswire
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
From Centogene NV
Via GlobeNewswire
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
From Centogene NV
Via GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in August
From Centogene NV
Via GlobeNewswire
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via GlobeNewswire
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
From Centogene NV
Via GlobeNewswire
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
From Centogene NV
Via GlobeNewswire
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.